Articles
Articles
All Articles
UPTM FTA: Early detection of diabetic kidney disease
In diabetic kidney disease, timing is everything. Traditionally, we wait for UACR and
2023 ASN Kidney Week Abstract: DNlite IVD103 with CKD and Coronary Artery Disease in Diabetic Nephropathy
A study supported by Bio Preventive Medicine Corp., "Association of Urinary DNlite IVD-103
Saudi FDA Approval Announcement
Bio Preventive Medicine Corp. announced on December 8, 2023 that its IVD products,
Taiwan FDA Approval Announcement
Bio Preventive Medicine Corp. announced on January 3, 2024 that its IVD product,
U.A.E. Approval Announcement
Bio Preventive Medicine Corp. announced that its IVD product, DNlite-DKD uPTM-FetA ELISA kit
DNlite-IVD103 received Market Authorization License from Ministry of Health of Vietnam
Bio Preventive Medicine Corp. (BPM) announced that its IVD product, DNlite-DKD uPTM-FetA ELISA
DNlite-IVD103 received registration license from Indonesian Ministry of Health
Bio Preventive Medicine Corp. (BPM) announced that its IVD product, DNlite-DKD uPTM-FetA ELISA
BPM signed an License MOU with Boditech Med Inc., a Korean company, to officially enter the POCT market with DNlite-IVD103
Bio Preventive Medicine Corp. (hereinafter referred to as "BPM", TW stock code: 6810)
Freenome Acquires Global Immunodiagnostics Developer Oncimmune Ltd
Press release to announce that ….
VIRTUAL WEBINAR: Learn More About Lung Cancer & COPD
To register: https://zoom.us/webinar/register/WM
Weavegen and Oncimmune signs distribution agreement
Weavegen and Oncimmune signs distribution agreement detail here
Oncimmune CE-mark kits
https://janesisbioscience.com/wp-content/uploads/2017/11/170531_Oncimmune-Kit-CE-Mark_FINAL.pdf
Ground-breaking blood test could reduce lung cancer deaths
https://news.sky.com/story/ground-breaking-blood-test-could-reduce-lung-cancer-deaths-11805344Source: Sky News 9 September 2019
Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling
Oncimmune Holdings plc (AIM:ONC.L), a leader in the development, manufacture and commercialisation of
Talk on Early Detection of Lung Cancer and Evaluation of the Indeterminate Pulmonary Nodule by James R. Jett
Singapore General Hospital on 7 March 2018 by invitation only
Importance of Early Cancer Detection
https://www.straitstimes.com/singapore/health/cgh-found-guilty-of-negligence-in-cancer-diagnosis
Oncimmune has been registered for use in Singapore since 2018
Janesis Bioscience is pleased to announce that Oncimmune Early CDT-Lung Test Kit is